Infectious Complications of Anti-Tumour Necrosis Factor-α Therapy in Rheumatoid Arthritis

QR Code

Infectious Complications of Anti-Tumour Necrosis Factor-α Therapy in Rheumatoid Arthritis

None

Saved in:

Bibliographic Details
Main Authors:	Xynos, Ioannis D., Sipsas, Nikolaos V.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26062
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysis
by: Emilie Gerard, et al.
Published: (2025-08-01)

Anti-Tumour Necrosis Factor-α Induced Systemic Lupus Erythematosus
by: Almoallim, Hani, et al.
Published: (2012)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Disseminated tuberculosis in a patient on anti-tumour necrosis factor (anti-TNF) therapy
by: Shantella Black, et al.
Published: (2025-07-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
by: O G Lineva, et al.
Published: (2010-02-01)

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
by: Agata N Burska, et al.
Published: (2015-01-01)

Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01)

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis
by: Tae-Jong Kim
Published: (2025-07-01)

Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
by: Vladimir Vasilyevich Badokin, et al.
Published: (2010-12-01)

USE OF TUMOR NECROSIS FACTOR-A INHIBITORS IN RHEUMATOID ARTHRITIS: TOPICAL ASPECTS
by: E L Luchikhina, et al.
Published: (2008-12-01)

Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal Diseases: a Literature Review
by: Maria Gerusa Brito Aragão, et al.
Published: (2016-06-01)

Perspectives of Quality of Life improvement in patients with rheumatoid arthritis with administration of fully human anti-tumor necrosis factor alpha monoclonal antibodies
by: V N. Amirdjanova
Published: (2008-06-01)

Complexity of immunobiology of tumor necrosis factor and novel anti-TNF therapy
by: S. А. Nedospasov
Published: (2023-06-01)

CO-EXPRESSION OF MEMBRANE-BOUND TUMOR NECROSIS FACTOR-α RECEPTORS IN MAJOR SUBPOPULATIONS OF IMMUNOCOMPETENT CELLS IN HEALTHY INDIVIDUALS AND PATIENTS WITH RHEUMATOID ARTHRITIS AS WELL AS BRONCHIAL ASTHMA
by: Yu. V. Zhukova, et al.
Published: (2021-10-01)

Infectious comorbidities in patients with rheumatoid arthritis: Status praesens
by: B. S. Belov, et al.
Published: (2019-09-01)

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2016-03-01)

INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE
by: O. P. Dudarenko, et al.
Published: (2016-01-01)

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study
by: E. Feist, et al.
Published: (2023-04-01)

Use of inhibitors of tumor necrosis factor α in women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2021-10-01)

The system of tumor necrosis factor α in the pathogenesis of autoimmune diabetes mellitus
by: T. S. Prokhorenko, et al.
Published: (2011-02-01)

The survival rate of therapy with tumor necrosis factor-αinhibitors: main causes and drug substitution tactics
by: E. V. Igolkina, et al.
Published: (2018-12-01)

IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01)

EFFICACY OF PANAVIR® AND ACYCLOVIR IN THE COMPLEX THERAPY OF HERPETIC INFECTION-COMPLICATED RHEUMATOID ARTHRITIS
by: O N Egorova, et al.
Published: (2009-06-01)

B-lymphocyte hemostasis and anti-B-cell therapy areas for rheumatoid arthritis
by: Ekaterina Valeryevna Suponitskaya, et al.
Published: (2013-11-01)

A new direction in the treatment of rheumatoid arthritis: anti-B cell therapy
by: G V Lukina, et al.
Published: (2009-02-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

Functional outcomes of rheumatoid arthritis during various proceduresof anti-inflammatory therapy
by: Natalya Vladimirovna Chichasova, et al.
Published: (2010-04-01)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. N. Silkov, et al.
Published: (2014-07-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

BIOBEHAVIORAL THERAPY OF RHEUMATOID ARTHRITIS
by: N. A. Shabanova, et al.
Published: (2013-04-01)

THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
by: Olga Nikolayevna Egorova, et al.
Published: (2014-02-01)

The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19
by: E. S. Aronova, et al.
Published: (2021-04-01)

Incidence of Toxoplasmosis in Psoriasis Patients and Possible Correlation with Tumor Necrosis Factor-α
by: Entsar J. Saheb, et al.
Published: (2020-03-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

INTERGENIC INTERACTIONS OF TUMOR NECROSIS FACTOR ALPHA, INTERLEUKIN 17, AND OSTEOPROTEGERIN IN THE IMMUNOPATHOGENESIS OF RHEUMATOID ARTHRITIS IN THE RUSSIAN POPULATION OF THE CHELYABINSK REGION
by: Yulia Chumacheva, et al.
Published: (2019-08-01)

THE EFFECT OF AN ANTI-TUMOR NECROSIS FACTOR-? AGENT ON DISEASE ACTIVITY,BLOOD RHEOLOGICAL PROPERTIES, AND THE ARTERIAL WALL IN PSORIATIC ARTHRITIS
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2010-06-01)

IFNα-INDUCED DENDRITIC CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR SENSITIVITY TO DEXAMETHASONE
by: E. R. Chernykh, et al.
Published: (2017-07-01)

Association of TNF-α and IL-6 Concentrations with Depression in Patients with Rheumatoid Arthritis
by: Jelena Mrđa, et al.
Published: (2025-06-01)

Choice of therapeutic tactics after failure of the first tumor necrosis factor-α inhibitor
by: N. V. Chichasova
Published: (2017-09-01)